|
US2016024223A1
|
|
Treating hepatitis B virus infections by administering receptor associated protein (RAP)
|
|
WO2013158913A1
|
|
Treating cancer
|
|
WO2013130188A1
|
|
Treating human immunodeficiency virus infections
|
|
US2013116186A1
|
|
Lubricin injections to maintain cartilage health
|
|
US2010203054A1
|
|
Wnt Proteins and Detection and Treatment of Cancer
|
|
AU2005218044A1
|
|
Diagnosis and Treatment of Malignant Neoplasms
|
|
KR20140018411A
|
|
Wnt proteins and detection and treatment of cancer
|
|
WO2006034328A2
|
|
Wnt proteins and detection and treatment of cancer
|
|
WO2006036175A2
|
|
Wnt proteins and detection and treatment of cancer
|
|
US7415381B2
|
|
Joint friction sensing
|
|
TW520984B
|
|
Non-invasive determination of blood components
|
|
CA2441016A1
|
|
Taurine compounds
|
|
US6960562B2
|
|
Tribonectin polypeptides and uses thereof
|
|
WO0198358A2
|
|
Compositions for identification and isolation of stem cells
|
|
WO0166144A2
|
|
Antineoplastic combination comprising an inhibitor of angiogenesis and an inhibitor of dna topoisomerase i enzyme activity
|
|
WO0160983A2
|
|
Treatment for bone disorders
|
|
WO0139763A2
|
|
Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumors
|
|
AU1590101A
|
|
Diagnosis and treatment of malignant neoplasms
|
|
US6489128B1
|
|
Methods for detecting cancer of the central nervous system
|
|
US6129911A
|
|
Liver stem cell
|
